CliffBio
small molecule

VYFEMLA

ETHINYL ESTRADIOL; NORETHINDRONE

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameVYFEMLA
Active ingredientETHINYL ESTRADIOL; NORETHINDRONE
Strength0.035MG;0.4MG
Dosage formTABLET
RouteORAL-28
ModalitySmall molecule
FDA approvalSeptember 2013
Marketing statusRX

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.